Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. - Wikidata - awgldk - TriplyDB

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

http://www.wikidata.org/entity/Q35992294

about

BMI and BMD: The Potential Interplay between Obesity and Bone Fragility Excessive Body Weight in Older Adults Weight loss in obese adults 65years and older: a review of the controversy The alliance of mesenchymal stem cells, bone, and diabetes Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy Calorie restriction in overweight older adults: Do benefits exceed potential risks?The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes.Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.Circulating sclerostin associated with vertebral bone marrow fat in older men but not women Consequences of obesity and weight loss: a devil's advocate position Moderate weight loss in obese and overweight men preserves bone quality.Multilevel Approach of a 1-Year Program of Dietary and Exercise Interventions on Bone Mineral Content and Density in Metabolic Syndrome--the RESOLVE Randomized Controlled Trial.The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?Weight Loss Interventions in Older Adults with Obesity: A Systematic Review of Randomized Controlled Trials Since 2005.Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial.Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.Effects of myokines on bone.Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults Relative influence of heritability, environment and genetics on serum sclerostin Interaction between Muscle and Bone.Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.Obesity-related inflammation: implications for older adults.Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?Bone-adiposity cross-talk: implications for pediatric obesity. A narrative review of literature.Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.Implications of exercise-induced adipo-myokines in bone metabolism.Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.Hormonal and systemic regulation of sclerostin.Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists.The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention.Increased sclerostin and bone turnover after diet-induced weight loss in type 2 diabetes: a post hoc analysis of the MADIAB trial.Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.Bone adaptation in response to treadmill exercise in young and adult mice.The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial.

P2860

Q26744811-8F8B3F80-E916-4539-A0D2-78BC1D074E93 Q26801548-0E8328A7-3DF3-43E3-AFA1-D6E65A1E4CBB Q27008343-1A42F5C9-2801-425C-A1FE-20066734E46F Q27012497-3DD95548-015D-4464-A16D-C55515E1FBDD Q28072006-C9E54FBA-3C50-4F16-8583-AA19B6FA9629 Q30251756-2E5EA5B7-3BCC-4DE1-8A3E-1340D48FDB4E Q34219386-B526885A-4F90-481E-B3D2-69E476AC21D7 Q34396458-BFBF9A61-39D8-4736-8405-DABD172163A5 Q34628276-C42CCF7E-0625-480A-A095-D9EC04DFB75A Q35033491-1B591DE2-BD07-44AA-ACFC-256E50A7918E Q35120263-C2BBBFE7-F65C-4BA6-958E-68BE4DCD7A26 Q35777359-18BE2161-64A3-48CF-B907-9DA76CB1E5DE Q35860523-A18BCE67-6193-486F-AE9B-50DFCEE06F2A Q35967442-5B2769A2-326B-47F4-A585-00BA6EF6E3D6 Q36136769-708B9C28-2902-42C3-8687-08908D9575E1 Q36807324-EAF53BCC-5BCE-41D4-94B7-4BEF15926989 Q37086296-977C62C3-F09E-4503-AC96-82A0A746070E Q37112054-1254F014-BC40-4022-8340-D555B6226D3A Q37361795-94CA4622-C73B-4487-AE4D-E9E6B03EE2B8 Q37521197-D1986473-5E2B-4E02-B501-850A6CA57154 Q37627846-29B4FD29-DDE4-474C-8D66-EBACC0197524 Q37673464-EBBCFC7D-06C7-4AC4-A8B0-BCDE62EFB3DA Q38134579-E9CD9B81-BA66-48CC-9784-E9FDDD7506F0 Q38162295-FD863751-F7F9-48E4-8024-1C0A18DEF355 Q38209810-AFB2755D-E9D4-4D81-9C42-E3E2AD8004D9 Q38386563-DC376DB4-9A70-40B4-8D3B-123DFC38B3D9 Q38503214-543F3B77-CCDB-4645-ABF7-418E2908393D Q38683297-D12C6D05-F315-425B-B3FF-E12730C85B26 Q38846381-40AA3D22-7D52-4B5A-BC3F-EEED37F4BFBC Q39018695-2D6B002F-09B7-4D20-850A-DE1B5CCC33A5 Q39037907-19425644-8122-49DB-9EEF-4DB93A0E306C Q39937522-2006A44B-52D6-4A91-90BB-9FF1CFB5DABC Q47175120-0FAF97C8-F77C-4014-A7D6-C1FC4F048CA3 Q47255490-001DE71B-5ABF-437F-8F57-890B129855DC Q47659784-0206A900-A338-414B-8AD8-32AED4C96BF9 Q49590399-6A99E447-C0EA-4BB8-BD22-32AD3DA10723 Q51161134-00EEFB4E-5438-493A-BFC7-DFFC9416617C Q51184839-A0C46293-A46E-49AC-9C0C-4916020A3991 Q55344691-B1EF45BF-23D9-49E0-87B2-076AC28B892A

P2860

Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training.

http://www.wikidata.org/entity/Q35992294

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Weight loss in obese older adu ...... revented by exercise training.

@ast

Weight loss in obese older adu ...... revented by exercise training.

@en

type

label

Weight loss in obese older adu ...... revented by exercise training.

@ast

Weight loss in obese older adu ...... revented by exercise training.

@en

prefLabel

Weight loss in obese older adu ...... revented by exercise training.

@ast

Weight loss in obese older adu ...... revented by exercise training.

@en

P1433

Q35992294-CD765C90-3B00-4B1B-8A63-1B8EA1CC5B56

P1476

Q35992294-D3A83740-26AF-4985-98C5-3AB6EF98E93D

P2093

Q35992294-0360A3EE-E1FD-4988-B2AA-AB1754B3D5F2

Q35992294-1F22EF58-5109-4D92-A8D7-00BB02197731

Q35992294-4F3C7A9A-35DB-4BDD-9452-3CF1639DC8B2

Q35992294-8756CAA8-F985-4213-92D7-DCD08A456465

Q35992294-A0B899A4-748F-40DC-B24F-941D81F057B1

Q35992294-C3EC406C-5994-42BB-830C-179F6755026B

Q35992294-EE911CF2-4991-4973-AAB6-040A10BF0779

P2860

Q35992294-0C40D577-9900-4AA2-951D-2212BD092F16

Q35992294-18AD5088-CA84-449F-9164-24A5824C4378

Q35992294-239F0F60-E5CE-4533-BF90-27701C62AE45

Q35992294-2C6A9E9D-A178-4E0F-9812-7E606DFF4810

Q35992294-2CCD6D94-D351-4D41-AB9C-A9557F1026FF

Q35992294-2EE2B107-D91E-425C-A8C9-CD4B624AD6E0

Q35992294-31067B4A-2299-48F3-A518-0EC47C85E91D

Q35992294-353C39B7-F034-4D0D-B508-2AEC68B80257

Q35992294-3A13EE7D-3F12-44A8-B80F-BA1BDD919788

Q35992294-3C2CE589-29BB-4D70-B4A9-EF00B613C5AA

P304

Q35992294-D018768A-B52B-4929-B743-B6867B072454

P31

Q35992294-39DEC807-BAD7-48B6-9A2D-4B54531C83A3

P356

Q35992294-6EE4D456-7B86-46CC-86A4-B64BB223D98A

P433

Q35992294-4FB8D72E-42BB-492F-967C-E352631E932F

P478

Q35992294-F8E64BDE-5D7D-4E9A-8269-2BB57D3C9FDE

P50

Q35992294-00CE68B2-E432-43FE-8ADF-B1CF6991F4A7

P577

Q35992294-9CDB6448-99DE-4990-A266-866808906BF0

P5875

Q35992294-943902B2-FC4D-46E8-A07F-59626DEA6EE9

P698

Q35992294-48A3200E-62D9-4EC8-8E63-7D5C47F85CFB

P921

Q35992294-E160B59C-AA4D-45EC-90FE-E43C002A3E48

P932

Q35992294-2D7FA9ED-92D0-4CB0-88ED-018928EAF56B

P356

P1433

Journal of Bone and Mineral Research

P1476

Weight loss in obese older adu ...... revented by exercise training.

@en

P2093

Clifford Qualls

http://www.w3.org/2001/XMLSchema#string

Corinn Sadler

http://www.w3.org/2001/XMLSchema#string

David R Sinacore

http://www.w3.org/2001/XMLSchema#string

Dennis T Villareal

http://www.w3.org/2001/XMLSchema#string

Krupa Shah

http://www.w3.org/2001/XMLSchema#string

Reina Armamento-Villareal

http://www.w3.org/2001/XMLSchema#string

Suresh Chode

http://www.w3.org/2001/XMLSchema#string

P2860

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation.

Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data.

Bone, body weight, and weight reduction: what are the concerns?

Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women.

Positive influence of long-lasting and intensive weight-bearing physical activity on hip structure of young adults.

Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

P304

1215-1221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.1560

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221890417

http://www.w3.org/2001/XMLSchema#string

P698

22392834

http://www.w3.org/2001/XMLSchema#string

P921

P932

3361603

http://www.w3.org/2001/XMLSchema#string